期刊文献+

非小细胞肺癌组织中PTEN基因和Ki67蛋白的表达及意义 被引量:2

Expression and significance of PTEN gene and Ki67 protein in non-small cell lung cancer
原文传递
导出
摘要 目的探讨第10染色体同源丢失性磷酸酶-张力蛋白基因(PTEN)和Ki67蛋白在肺癌组织中的表达及其临床意义。方法采用免疫组化方法检测67例非小细胞肺癌(NSCLC)组织(A组)及41例癌旁正常肺组织(B组)中PTEN基因和Ki67蛋白的表达。结果 A组PTEN基因阳性表达率显著低于B组(32.84%vs.82.93%),而Ki67表达则显著高于B组(76.12%vs.27.31%)(P<0.05)。PTEN基因和Ki67的表达与肺癌的TNM分期、临床分期、淋巴结转移和4年生存率密切相关(P<0.05)。NSCLC的PTEN基因表达与Ki67呈负相关(r=-0.239,P<0.05)。Kaplan-Meier生存曲线分析显示,NSCLC的PTEN表达下调和Ki67表达上调者,术后生存率下降。结论联合检测PTEN与Ki67的表达有助于判断非小细胞肺癌的预后。 Objective To study the expressions and significance of tenth chromosome phosphatase and tension homology deleted protease gene(PTEN gene) and Ki67 protein in non-small cell lung cancer (NSCLC). Methods The expressions of PTEN and Ki67 were detected by immunohistochemistry in NSCLC of 67 patients(group A) and tumor-adjacent normal lung tissues of 41 samples(group B). Results The positive expression rate of PTEN in group A was significantly lower than that in group B (32.84% vs. 82.93%)(P〈0. 05). The expression of Ki67 was significantly higher in group A than that in group B(76.12% vs. 27.31%) (P〈0.05). The expressions of PTEN and Ki67 were closely correlated with TNM grade, clinical stage, lymph node metastasis and 4-year survival rate after surgery(P〈0. 05). The expression of PTEN was negatively correlated to that of Ki67 (r=- 0. 239, P〈0. 05). Kaplan-Meier analysis showed that downregulated expression of PTEN and upregulated expression of Ki67 were associated with lower survival rate in NSCLC patients after surgery. Conclusion Combined detection of the expressions of PTEN and Ki67 in NSCLC can be taken as the indicators for evaluating the prognosis of NSCLC patients.
出处 《江苏医药》 CAS 北大核心 2013年第21期2535-2537,F0003,共4页 Jiangsu Medical Journal
基金 国家十一五科技攻关重大资助项目(2008BAI0B05) 国家自然科学基金(面上项目)(81070074-H0116)
关键词 非小细胞肺癌 第10号染色体同源丢失性磷酸酶-张力蛋白基因Ki67 Non-small cells lung carcinoma PTEN gene Ki67
  • 相关文献

参考文献10

  • 1Lee S,Choi EJ,Jin C,et al. Activation of PI3K/Akt pathway by PTEN reduction and P1K3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line[J] Gynecol Oncol, 2005,97 (1) : 26-34.
  • 2Leonardo E,Volante M, Barbareschi M, et al. Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact[J1. Appl hnmunohistochem Mol Morphol, 2007, 15 (2) :220-223.
  • 3陈昊,李玉民,何明彦,李汛,周文策,孟文勃,张磊.胃不典型增生和癌组织中Ki67和PTEN蛋白的表达及意义[J].中国普外基础与临床杂志,2007,14(3):304-307. 被引量:18
  • 4陈雪松,赵艳滨,蔡莉,孙立春,孟庆威,庞慧,隋广杰.血管紧张素Ⅱ受体1、VEGF和PTEN在乳腺癌中的表达及临床意义[J].中国肿瘤,2008,17(3):230-232. 被引量:5
  • 5van Rijn SJ, Grinwis GC, Penning LC, et al. Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas[J] Domest Anim Endocrin,2010,38(4):244-252.
  • 6Wang Y, Wang X, Zhang J, et al. MieroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas[J]. J Neuro- oncol, 2012, 106(2) :217-224.
  • 7Ettl T, Baader K, Stiegler C, et al. Loss of PTEN is associ- ated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer[J]. Brit J Cancer, 2012, 106(4) : 719-726.
  • 8Yoshimoto M, Cutz JC, Nuin PA, et al. Interphase FISH analysis of PTEN in histologic of sections shows genomic deletions in 68% of primary prostate cancer and 23: high- grade prosraticintra-epithelial neoplasias[J] Cancer Genet Cytogenet, 2006,16 (9) .. 128-137.
  • 9Gallardo A, Lerma E, Escuin D, et al. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas[J]. Brit J Cancer, 2012, 106 (8): 1367- 1373.
  • 10Kinross KM, Montgomery KG, Kleinschmidt M, et al. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice[J]. J Clin Invest, 2012, 122(2) :553-557.

二级参考文献16

  • 1陈道达,陈剑英.早期胃癌诊断中的问题及可行对策[J].中国普外基础与临床杂志,2006,13(1):7-8. 被引量:4
  • 2王舒宝,王俊.胃癌复发与转移的有关问题及综合治疗[J].中国普外基础与临床杂志,2006,13(1):9-11. 被引量:33
  • 3Hao Deng,Ren-Liang Wu,Hong-Yan Zhou,Xuan Huang,Ying Chen,Li-Jiang Liu.Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer[J].World Journal of Gastroenterology,2006,12(7):1013-1017. 被引量:27
  • 4Koh W, Tuan JM, Sun CL, et al. Angiotensin Ⅰ -converting enzyme (ACE) genepolymorphism and breast cancer risk among Chinese women in Singapore [J]. Cancer Res, 2003, 63(3):573-578.
  • 5Suganuma T, Ino K, Shibata K, et al.Functional expression of the angiotensin Ⅱ type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination[J]. Clin Cancer Res, 2005, 11 (7):2686- 2694.
  • 6Uemura H,Ishiguro H, Nakaigawa N, et al. Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor[J]. Mol Cancer Ther,2003,2 ( 11 ):1139-1147.
  • 7Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression[J]. Am Pathol, 2001, 158(5):1633-1637.
  • 8Kikkawa F, Mizuno M, Shibata K, et al. Activation of invasiveness of cervical carcinoma cells by angiotensin Ⅱ [J]. Am J Obstet Gynecol, 2004, 190(5):1258-1263.
  • 9Dinh DT, Frauman AG, Sourial M, et al. Identification, distribution, and expression of angiotensin Ⅱ receptors in the normal human prostate and benign prostatic hyperplasia [J]. Endocrinology, 2001, 142(3):1349-1356.
  • 10De Paepe B, Verstraeten VL, Depotter CR, et al. Growth stimulatory angiotensin Ⅱ type-lreceptor is upregulated in breast hyperplasia and in situ carcinomabut not in invasire carcinoma[J]. Histochem Cell Biol, 2001, 116(3): 247-254.

共引文献19

同被引文献26

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部